stock
INCY · INCYTE CORP
What INCYTE CORP reports to the SEC, read from its filings.
Open in the appPrice
The live INCY price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on INCY.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 199,782,155 as of 2026-04-21 (XBRL frame CY2026Q1I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- 30.0%
- Net
- 26.7%
Returns
- ROE
- 25.5%
- ROA
- 19.5%
Health
- Current ratio
- 3.7x
- Debt/equity
- —
Deep value
- NCAV
- $3.77B
- NCAV per share
- $18.86
- Price/NCAV
- Locked
- NNWC
- $1.80B
- NNWC per share
- $9.02
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-03-31; balance sheet at 2026-03-31.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-03-31 | $1.27B | —Gross profit: unreported by this company. | $301.12M | $303.33M | 10-Q filed 2026-04-28 |
| 2025-12-31 | $1.51B | —Gross profit: unreported by this company. | $335.86M | $299.33M | DEF 14A filed 2026-04-28 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $1.37B | —Gross profit: unreported by this company. | $443.52M | $424.17M | 10-Q filed 2025-10-28 |
| 2025-06-30 | $1.22B | —Gross profit: unreported by this company. | $530.31M | $405.00M | 10-Q filed 2025-10-28 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-03-31 | $1.05B | —Gross profit: unreported by this company. | $205.17M | $158.20M | 10-Q filed 2026-04-28 |
| 2024-12-31 | $1.18B | —Gross profit: unreported by this company. | $301.51M | $201.20M | DEF 14A filed 2026-04-28 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $1.14B | —Gross profit: unreported by this company. | $146.09M | $106.46M | 10-Q filed 2025-10-28 |
| 2024-06-30 | $1.04B | —Gross profit: unreported by this company. | -$478.13M | -$444.60M | 10-Q filed 2025-10-28 Assembled from more than one filing; the filing above is only the newest of them. |
- Assets
- $7.34B
- Equity
- $5.62B
Balance as of 2026-03-31.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $5.14B | $1.51B | $1.29B | — |
| 2024-12-31 | $4.24B | $61.37M | $32.60M | — |
| 2023-12-31 | $3.70B | $620.52M | $597.60M | — |
| 2022-12-31 | $3.39B | $579.44M | $340.70M | — |
| 2021-12-31 | $2.99B | $585.78M | $948.60M | — |
| 2020-12-31 | $2.67B | -$263.68M | -$295.70M | — |
| 2019-12-31 | $2.16B | $402.01M | $446.91M | — |
| 2018-12-31 | $1.88B | $129.22M | $109.49M | — |
| 2017-12-31 | $1.54B | -$243.39M | -$313.14M | — |
| 2016-12-31 | $1.11B | $145.00M | $104.22M | — |
Company filings
events
5% owners ()
Dodge & Cox
Stake update
Baker Bros. Advisors LP
Stake update
Vanguard Capital Management
Passive stake
The Vanguard Group
Stake update
Baker Bros. Advisors LP
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
CAGNONI PABLO J
President, Global Head of R&D
Sale$2,797,629Sep 17, 4:04 PM ET
CAGNONI PABLO J
President, Global Head of R&D
Sale$1,356,174Aug 20, 5:15 PM ET
CAGNONI PABLO J
President, Global Head of R&D
Sale$1,296,792Aug 14, 4:01 PM ET
CAGNONI PABLO J
President, Global Head of R&D
Sale$1,305,422Aug 7, 4:02 PM ET
Mayes Patrick A
EVP & Chief Scientific Officer
Sale$273,646Aug 7, 4:01 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- Dodge & Cox
Period Tue 30 Jun 2026
0.7%Trimmed - Bridgewater Associates
Period Tue 30 Jun 2026
0.1%Added
News
Stories that named INCY, and the market events around them.
Sign in to see thisBoard
The INCY board could not be loaded.
Retry the INCY boardnakagai
Signals on INCY come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the INCY board